These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32434006)

  • 21. Profound intellectual disability caused by homozygous TRAPPC9 pathogenic variant in a man from Malta.
    Wilton KM; Gunderson LB; Hasadsri L; Wood CP; Schimmenti LA
    Mol Genet Genomic Med; 2020 May; 8(5):e1211. PubMed ID: 32162493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAPPC9-related autosomal recessive intellectual disability: report of a new mutation and clinical phenotype.
    Marangi G; Leuzzi V; Manti F; Lattante S; Orteschi D; Pecile V; Neri G; Zollino M
    Eur J Hum Genet; 2013 Feb; 21(2):229-32. PubMed ID: 22549410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational analysis of TRAPPC9: candidate gene for autosomal recessive non-syndromic mental retardation.
    Khattak NA; Mir A
    CNS Neurol Disord Drug Targets; 2014; 13(4):699-711. PubMed ID: 24040793
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Uctepe E; Yesilyurt A; Esen FN; Tumer S; Mancilar H; Sonmez FM
    Mol Syndromol; 2023 Dec; 14(6):485-492. PubMed ID: 38058760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of CNVs in the etiology of rare autosomal recessive disorders: the example of TRAPPC9-associated intellectual disability.
    Mortreux J; Busa T; Germain DP; Nadeau G; Puechberty J; Coubes C; Gatinois V; Cacciagli P; Duffourd Y; Pinard JM; Tevissen H; Villard L; Sanlaville D; Philip N; Missirian C
    Eur J Hum Genet; 2018 Jan; 26(1):143-148. PubMed ID: 29187737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NFκB-inducing kinase inhibits NFκB activity specifically in neurons of the CNS.
    Mao X; Phanavanh B; Hamdan H; Moerman-Herzog AM; Barger SW
    J Neurochem; 2016 Apr; 137(2):154-63. PubMed ID: 26778773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of NIBP and its clinical significance in human early colorectal cancer.
    Li L; Yang W; Yue H; He F; Xu S; Wei Q; Chen P; Peng Q; Deng S; Long P
    Int J Clin Exp Pathol; 2017; 10(8):8633-8639. PubMed ID: 31966720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trappc9 deficiency in mice impairs learning and memory by causing imbalance of dopamine D1 and D2 neurons.
    Ke Y; Weng M; Chhetri G; Usman M; Li Y; Yu Q; Ding Y; Wang Z; Wang X; Sultana P; DiFiglia M; Li X
    Sci Adv; 2020 Nov; 6(47):. PubMed ID: 33208359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G protein-coupled receptor trafficking and signaling: new insights into the enteric nervous system.
    Carbone SE; Veldhuis NA; Gondin AB; Poole DP
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G446-G452. PubMed ID: 30702900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation.
    Philippe O; Rio M; Carioux A; Plaza JM; Guigue P; Molinari F; Boddaert N; Bole-Feysot C; Nitschke P; Smahi A; Munnich A; Colleaux L
    Am J Hum Genet; 2009 Dec; 85(6):903-8. PubMed ID: 20004764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of Intellectual Disability-Related Genes to ADHD Risk and to Locomotor Activity in
    Klein M; Singgih EL; van Rens A; Demontis D; Børglum AD; Mota NR; Castells-Nobau A; Kiemeney LA; Brunner HG; Arias-Vasquez A; Schenck A; van der Voet M; Franke B
    Am J Psychiatry; 2020 Jun; 177(6):526-536. PubMed ID: 32046534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice.
    Rawlins LE; Almousa H; Khan S; Collins SC; Milev MP; Leslie J; Saint-Dic D; Khan V; Hincapie AM; Day JO; McGavin L; Rowley C; Harlalka GV; Vancollie VE; Ahmad W; Lelliott CJ; Gul A; Yalcin B; Crosby AH; Sacher M; Baple EL
    PLoS Genet; 2022 Mar; 18(3):e1010114. PubMed ID: 35298461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct isocomplexes of the TRAPP trafficking factor coexist inside human cells.
    Kümmel D; Oeckinghaus A; Wang C; Krappmann D; Heinemann U
    FEBS Lett; 2008 Nov; 582(27):3729-33. PubMed ID: 18930054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trafficking and signaling of G protein-coupled receptors in the nervous system: implications for disease and therapy.
    Bunnett NW; Cottrell GS
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):539-56. PubMed ID: 20632972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway.
    Willmann KL; Sacco R; Martins R; Garncarz W; Krolo A; Knapp S; Bennett KL; Boztug K
    J Proteome Res; 2016 Sep; 15(9):2900-2909. PubMed ID: 27416764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging roles for angiomotin in the nervous system.
    Wigerius M; Quinn D; Fawcett JP
    Sci Signal; 2020 Oct; 13(655):. PubMed ID: 33109746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM; Lee DW; Jung JU; Sitcheran R
    Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation.
    Hu WH; Mo XM; Walters WM; Brambilla R; Bethea JR
    J Biol Chem; 2004 Aug; 279(34):35975-83. PubMed ID: 15208311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.